Hedge Fund · CIK 0001138995
Larry Robbins
Glenview Capital
Larry Robbins runs Glenview Capital, a hedge fund overseeing $4.91B in disclosed equity holdings (SEC CIK 0001138995). The latest 13F filing (2025Q4) discloses 54 positions across 8 sectors, with the largest positions in CVS, TEVA and GPN. On a mark-to-market basis the tracked portfolio has returned 24.9% over the past year. OpenStocks tracks 40 consecutive 13F filings for this manager — every position change, new entry, and exit is logged below.
Portfolio
$4.91B
Positions
54
Quarter
2025Q4
Filings tracked
40
Biggest winner since filing
THCTENET HEALTHCARE CORP
+242.7%
+$1.05B
Biggest loser since filing
DXCDXC TECHNOLOGY CO
-51.6%
−$176.2M
Investment strategy
Larry Robbins is a mid-size fund tilted toward healthcare names. 54% of the disclosed equity book is in Healthcare.
Embed this chart
Paste this iframe anywhere to embed the live CI chart.
<iframe src="https://openstocks.me/embed/stock/CI" width="100%" height="480" frameborder="0" loading="lazy" title="CI chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>Preview: https://openstocks.me/embed/stock/CI
Holdings
7 sectors41 positions
Top 3 = 33% of book · CI, THC, DXC
View full portfolio →
Performance
vs SPY40 quarters tracked
Mark-to-market portfolio growth vs SPY benchmark, with AUM and concentration history.
View performance →
Options & derivatives
Bearish bets3 option positions
Largest: PUT IWM ($318.6M notional)
View options →
Activity & trades
Quarter-by-quarterLast move 2025Q4
SOLD G4705A100 — and 4 more recent moves.
View activity →
Recent transactions
See full activity →TRIM
THERMO FISHER SCIENTIFIC INC
−58,994
~$579.45 · 2025Q4
2026-02-17
NEW
SENSIENT TECHNOLOGIES CORP
+50,000
~$93.95 · 2025Q4
2026-02-17
ADD
BAUSCH PLUS LOMB CORP
+100,000
~$17.08 · 2025Q4
2026-02-17
